This latest report is a study published in the British Journal of Haematology comparing whole-body ultra-low dose CT (WBULDCT) with spinal MRI...
Myeloma NZ
Drugs for incurable blood cancer ‘should be available’
About 400 New Zealanders a year are diagnosed with the blood cancer multiple myeloma, and the number is rising. A malignancy of the plasma cell, it...
Article of the week: Monoclonal antibody therapy in multiple myeloma
This review discusses pre-clinical and clinical studies on the use of monoclonal antibodies in multiple myeloma, including agents which have been...
Launch
On November 22, Â 2016 Â in Wellington a group of New Zealand based hematology specialists led by Kenneth Romeril launched a new initiative for...